Brought to you by 
Seegene raises $16.6mm in IPO on Korean exchange
01 Nov 2010
Executive Summary
Molecular diagnostics firm Seegene Inc. completed a $16.6mm initial public offering on Kosdaq (Korea Securities Dealers Automated Quotations). It sold 636.5k shares at $26.16. The company says it will also attempt an IPO on Nasdaq in three years.
Deal Industry
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com